Registered Number 06475379

ABINGDON HEALTH LTD

Abbreviated Accounts

31 December 2011

ABINGDON HEALTH LTD Registered Number 06475379

Abbreviated Balance Sheet as at 31 December 2011

Notes 31/12/2011 30/06/2011
£ £
Fixed assets
Tangible assets 2 668 531
Investments 3 250,000 250,000
250,668 250,531
Current assets
Debtors 22,924 4,317
Cash at bank and in hand 65,689 46,047
88,613 50,364
Creditors: amounts falling due within one year (6,699) (9,102)
Net current assets (liabilities) 81,914 41,262
Total assets less current liabilities 332,582 291,793
Creditors: amounts falling due after more than one year (378,726) (384,590)
Total net assets (liabilities) (46,144) (92,797)
Capital and reserves
Called up share capital 4 1,696 1,526
Profit and loss account (47,840) (94,323)
Shareholders' funds (46,144) (92,797)
  • For the year ending 31 December 2011 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
  • The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  • The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  • These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 25 January 2013

And signed on their behalf by:
Dr Brett Pollard, Director

ABINGDON HEALTH LTD Registered Number 06475379

Notes to the Abbreviated Accounts for the period ended 31 December 2011

1Accounting Policies

Basis of measurement and preparation of accounts
The accounts have been prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities effective April 2008.

Tangible assets depreciation policy
Depreciation is provided on tangible fixed assets so as to write off the cost or valuation, less any estimated residual value, over their expected useful economic life as follows:
Computer equipment 20% straight line

2Tangible fixed assets
£
Cost
At 1 July 2011 2,543
Additions 532
Disposals -
Revaluations -
Transfers -
At 31 December 2011 3,075
Depreciation
At 1 July 2011 2,012
Charge for the year 395
On disposals -
At 31 December 2011 2,407
Net book values
At 31 December 2011 668
At 30 June 2011 531

3Fixed assets Investments
The company owns 50% of the ordinary shares in Bioscience Ventures Limited, a company whose principal activity is managing investments.

4Called Up Share Capital
Allotted, called up and fully paid:
31/12/2011
£
30/06/2011
£
1,696 Ordinary shares of £1 each (1,526 shares for 30/06/2011) 1,696 1,526

During the period 170 ordinary shares with an aggregate nominal value of £170 were allotted for an aggregate consideration of £170.

5Transactions with directors

Name of director receiving advance or credit: Dr Christopher Hand
Description of the transaction: Loan to the company at 7.5% interest
Balance at 1 July 2011: £ 262,585
Advances or credits made: £ 9,847
Advances or credits repaid: -
Balance at 31 December 2011: £ 272,432

Name of director receiving advance or credit: Dr Christopher Hand
Description of the transaction: Loan to the company interest free
Balance at 1 July 2011: £ 122,005
Advances or credits made: -
Advances or credits repaid: £ 15,711
Balance at 31 December 2011: £ 106,294

Name of director receiving advance or credit: Dr Brett Pollard
Description of the transaction: Balance owing to director
Balance at 1 July 2011: £ 0
Advances or credits made: £ 2,486
Advances or credits repaid: -
Balance at 31 December 2011: £ 2,486